Innovative Medicines Initiative selects proposals

Europe's Innovative Medicines Initiative (IMI) selected 15 proposals to receive EUR 246 million ($332 million) under a five-year, EUR 2 billion program to relieve bottlenecks in drug discovery and development. The projects will receive EUR 110 million from the EC with an in-kind contribution of EUR 136 million from participating European Federation of Pharmaceutical Industries and Associations (EFPIA) members.

The 15 projects involve improving safety prediction and pharmacovigilance; improving prediction of efficacy in diabetes and brain and respiratory disorders; and education and training in support of medicines development. ...